New biopsy technique could unlock better lung cancer treatments

NCT ID NCT06105801

Recruiting now Knowledge-focused Sponsor: Vanderbilt-Ingram Cancer Center Source: ClinicalTrials.gov ↗

First seen Feb 02, 2026 · Last updated Jun 17, 2026 · Updated 23 times

Summary

This study compares two ways of taking tissue samples from lung cancer tumors to see which method gives better material for genetic testing. About 250 adults with suspected lung cancer will be randomly assigned to get either a standard needle biopsy or a newer freezing biopsy. The goal is to find out which method provides enough high-quality tissue for tests that help doctors choose the most effective treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Vanderbilt University/Ingram Cancer Center
RECRUITING

Nashville, Tennessee, 37232, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER